Y-mAbs Therapeutics Files 2024 Annual Report Amendment
| Field | Detail |
|---|---|
| Company | Y-Mabs Therapeutics, Inc. |
| Form Type | 10-K/A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
Y-mAbs filed its 2024 10-K amendment. Check for updates.
AI Summary
Y-mAbs Therapeutics, Inc. filed an amendment to its 2024 annual report on April 29, 2025. This filing pertains to the fiscal year ending December 31, 2024. The company is incorporated in Delaware and its principal business address is in Princeton, NJ.
Why It Matters
This amendment provides updated information for the fiscal year 2024, which is crucial for investors to assess the company's financial health and strategic direction.
Risk Assessment
Risk Level: low — This filing is an amendment to a standard annual report, not indicating new material risks.
Key Numbers
- 001-38650 — SEC File Number (Identifies the company's filings with the SEC.)
- 25882274 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- Y-mAbs Therapeutics, Inc. (company) — Filer of the 10-K/A
- 2024 (date) — Fiscal year end
- April 29, 2025 (date) — Filing date of the amendment
- Princeton, NJ (location) — Company business address
- Delaware (location) — State of incorporation
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is an amendment to the annual report for the fiscal year ended December 31, 2024, but the specific details of the amendments are not provided in this header information.
When was the original 10-K filed for the fiscal year ended December 31, 2024?
The filing date of this amendment is April 29, 2025, indicating the original filing would have been prior to this date.
What is Y-mAbs Therapeutics, Inc.'s primary business sector?
Y-mAbs Therapeutics, Inc. is in the Pharmaceutical Preparations sector, with SIC code 2834.
Where is Y-mAbs Therapeutics, Inc. headquartered?
The company's business and mailing address is located at 202 Carnegie Center, Suite 301, Princeton, NJ 08540.
In which state is Y-mAbs Therapeutics, Inc. incorporated?
Y-mAbs Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding Y-mAbs Therapeutics, Inc..